1 terminated, 1 withdrawn. 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
| Phase 4 | 1 | Terminated 1 |
Follow Placebo (for diazoxide): new trials by email Literature Review of Placebo (for diazoxide) trials Research Report on Placebo (for diazoxide)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Role of Hepatic Denervation in the Dysregulation of Glucose Metabolism in Liver Transplant Recipients Diazoxide, Placebo (for diazoxide), Nicotinic acid - Diabetes Mellitus, Type 2, Glucose, High Blood | Phase 2 | Withdrawn | Albert Einstein College of Medicine | 2019-04-21 | 2023-06-05 | |
| Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF) Naloxone, Diazoxide, Placebo (for Naloxone) - Diabetes Mellitus, Type 1, Hypoglycemia | Phase 4 | Terminated | Albert Einstein College of Medicine | 4 | 2019-01-08 | 2025-09-11 |
Diabetes Mellitus (2) · Diabetes Mellitus, Type 1 (1) · Diabetes Mellitus, Type 2 (1) · Glucose Metabolism Disorders (1) · Hypoglycemia (1) · Insulin Resistance (1)
Albert Einstein College of Medicine (2)
United States (2)
Meredith Hawkins, M.D., M.S. (1) · Meredith Hawkins, MD, MS (1)
R01DK079974 (1)